Department of Andrology, Reproductive Biomedicine Research Center, Royan Institute for Reproductive Biomedicine, Academic Center for Education, Culture and Research, Tehran, Iran.
Urology. 2013 Dec;82(6):1291-5. doi: 10.1016/j.urology.2013.06.041. Epub 2013 Oct 2.
To study the sperm deoxyribonucleic acid (DNA) fragmentation index (DFI), testicular volume, semen parameters, and hormone profile in human chorionic gonadotropin (hCG)- and human menopausal gonadotrophin (hMG)-treated patients with hypogonadotropic hypogonadism (HH) with and without a successful pregnancy.
This is a cross sectional study. The study initially included 81 patients with HH and azoospermia at the Infertility Unit of Royan Institute between 2010 and 2012. Fifty-eight of 81 patients achieved >1 × 10(6) sperm/mL during hCG and hMG therapy. These 58 patients were divided into the following 2 groups: 20 patients with HH who achieved pregnancy in response to hCG/hMG (responders, 16 naturally and 4 by intrauterine insemination) and 38 gonadotropin-treated patients with HH with failed pregnancy (nonresponders, 29 naturally, 5 by intrauterine insemination, 1 by in vitro fertilization, and 3 by intracytoplasmic sperm injection). Sperm DNA fragmentation was visualized by terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) assay.
Average of DFI (responders: 13.45 ± 0.64; nonresponders: 21.92 ± 0.86), age, body mass index, testis volume semen parameters, and follicle-stimulating hormone, luteinizing hormone, and testosterone levels in the 2 groups were calculated. Cut-off point for DFI was determined by receiver operating curve analysis (17.5%).
It was shown that DFI in responders is significantly lower than DFI in nonresponders (P <.001), and duration of hCG and hMG therapy in responders is significantly higher than those of nonresponders (P <.05). DFI could be predictive of conception (P <.001; odds ratio 0.57; 95% confidence interval 0.417-0.778). It can be concluded that despite low sperm quality, especially sperm concentration in these patients, decreasing sperm DNA damage may result in successful fertilization.
研究人绒毛膜促性腺激素(hCG)和人绝经期促性腺激素(hMG)治疗低促性腺激素性性腺功能减退症(HH)伴和不伴成功妊娠患者的精子脱氧核糖核酸(DNA)碎片化指数(DFI)、睾丸体积、精液参数和激素谱。
这是一项横断面研究。该研究最初纳入了 2010 年至 2012 年期间在罗扬研究所不孕不育科就诊的 81 例 HH 伴无精子症患者。81 例患者中有 58 例在 hCG 和 hMG 治疗后精子浓度达到>1×10(6)/ml。这 58 例患者分为以下两组:20 例 HH 患者对 hCG/hMG 有妊娠反应(应答者,16 例自然妊娠,4 例宫腔内人工授精)和 38 例促性腺激素治疗后 HH 妊娠失败的患者(无应答者,29 例自然妊娠,5 例宫腔内人工授精,1 例体外受精,3 例胞浆内单精子注射)。采用末端脱氧核苷酸转移酶 dUTP 缺口末端标记法(TUNEL)检测精子 DNA 碎片化。
计算两组患者的 DFI 平均值(应答者:13.45±0.64;无应答者:21.92±0.86)、年龄、体重指数、睾丸体积、精液参数、卵泡刺激素、黄体生成素和睾酮水平。通过受试者工作特征曲线分析确定 DFI 的截断值(17.5%)。
结果表明,应答者的 DFI 明显低于无应答者(P<0.001),应答者的 hCG 和 hMG 治疗时间明显长于无应答者(P<0.05)。DFI 可以预测妊娠(P<0.001;优势比 0.57;95%置信区间 0.417-0.778)。可以得出结论,尽管这些患者的精子质量低,尤其是精子浓度低,但降低精子 DNA 损伤可能会导致受精成功。